These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8946471)

  • 61. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.
    De Morais SM; Wilkinson GR; Blaisdell J; Meyer UA; Nakamura K; Goldstein JA
    Mol Pharmacol; 1994 Oct; 46(4):594-8. PubMed ID: 7969038
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
    Johansson I; Oscarson M; Yue QY; Bertilsson L; Sjöqvist F; Ingelman-Sundberg M
    Mol Pharmacol; 1994 Sep; 46(3):452-9. PubMed ID: 7935325
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
    Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
    Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease.
    Bordet R; Broly F; Destee A; Libersa C
    Clin Neuropharmacol; 1994 Oct; 17(5):484-8. PubMed ID: 9316701
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CYP2D6 genotyping in patients on psychoactive drug therapy.
    Topić E; Stefanović M; Ivanisević AM; Blazinić F; Culav J; Skocilić Z
    Clin Chem Lab Med; 2000 Sep; 38(9):921-7. PubMed ID: 11097351
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A BamHI polymorphism in the human cytochrome P450 gene, CYP2D6.
    Morimoto Y; Murayama N; Kuwano A; Yoshimura O; Kondo I
    Clin Genet; 1995 Feb; 47(2):103-4. PubMed ID: 7606840
    [No Abstract]   [Full Text] [Related]  

  • 67. Mutation analysis of CYP2D6 locus in the Korean population: identification of rare poor metabolizer alleles at the nucleotide level.
    Ryu SW; Kim YJ; Kim E
    Mol Cells; 1998 Dec; 8(6):758-63. PubMed ID: 9895131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.
    Ebner T; Eichelbaum M
    Br J Clin Pharmacol; 1993 Apr; 35(4):426-30. PubMed ID: 8485023
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations.
    Gaedigk A; Isidoro-García M; Pearce RE; Sánchez S; García-Solaesa V; Lorenzo-Romo C; Gonzalez-Tejera G; Corey S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):859-64. PubMed ID: 20473659
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population.
    Niewinski P; Orzechowska-Juzwenko K; Hurkacz M; Rzemislawska Z; Jaźwinska-Tarnawska E; Milejski P; Forkasiewicz Z
    Eur J Clin Pharmacol; 2002 Nov; 58(8):533-5. PubMed ID: 12536989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
    Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ
    Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.
    Gaedigk A; Gotschall RR; Forbes NS; Simon SD; Kearns GL; Leeder JS
    Pharmacogenetics; 1999 Dec; 9(6):669-82. PubMed ID: 10634130
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.
    Zanger UM; Raimundo S; Eichelbaum M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):23-37. PubMed ID: 14618296
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast.
    Ellis SW; Ching MS; Watson PF; Henderson CJ; Simula AP; Lennard MS; Tucker GT; Woods HF
    Biochem Pharmacol; 1992 Aug; 44(4):617-20. PubMed ID: 1510710
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes.
    Daly AK; Armstrong M; Monkman SC; Idle ME; Idle JR
    Pharmacogenetics; 1991 Oct; 1(1):33-41. PubMed ID: 1688241
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
    Aklillu E; Persson I; Bertilsson L; Johansson I; Rodrigues F; Ingelman-Sundberg M
    J Pharmacol Exp Ther; 1996 Jul; 278(1):441-6. PubMed ID: 8764380
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PCR-based CYP2D6 genotyping for Finnish lung cancer patients.
    Hirvonen A; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Pelkonen O; Vainio H
    Pharmacogenetics; 1993 Feb; 3(1):19-27. PubMed ID: 8097947
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.
    Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacoz-Aigrain E; Krishnamoorthy R
    Br J Clin Pharmacol; 1995 Oct; 40(4):361-7. PubMed ID: 8554938
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.
    Fukuda T; Nishida Y; Zhou Q; Yamamoto I; Kondo S; Azuma J
    Eur J Clin Pharmacol; 2000 May; 56(2):175-80. PubMed ID: 10877013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Frequency of certain single-nucleotide polymorphisms and duplication of CYP2D6 in the Jordanian population.
    Zihlif M; Imraish A; Irshaid YM
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1201-5. PubMed ID: 22905959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.